InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

8.59
Delayed Data
As of 3:59pm ET
 +0.34 / +4.12%
Today’s Change
7.71
Today|||52-Week Range
106.25
-55.38%
Year-to-Date
Institutional investors purchased a net $202.4 thousand shares of NVIV during the quarter ended September 2017 and now own 10.38% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional6.13%
Mutual fund holders4.25%
Individual stakeholders0.65%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2018WELCH & FORBES LLC  Sold 3.0 Thousand shares of InVivo Therapeutics Holdi...

Top 10 Owners of InVivo Therapeutics Holdings Corp

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
The Vanguard Group, Inc.2.07%789,107422,172-14,685-1.83%
IMS Capital Management, Inc.1.64%624,673334,200+128,864+25.99%
BlackRock Fund Advisors1.49%568,643304,224+3,716+0.66%
Baker Bros. Advisors LP0.87%331,393177,295-68,607-17.15%
Millennium Management LLC0.56%211,190112,987-165,761-43.97%
Geode Capital Management LLC0.46%173,84293,005-5,960-3.31%
Morgan Stanley Smith Barney LLC (...0.39%149,43879,949-85,774-36.47%
Bridgeway Capital Management, Inc...0.38%145,65077,92300.00%
Wedbush Securities, Inc. (Investm...0.26%98,25552,566+48,255+96.51%
Welch & Forbes LLC0.26%97,41352,116-2,980-2.97%

Top 10 Mutual Funds Holding InVivo Therapeutics Holdings Corp

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change